PDB Short entry for 2NV3
HEADER    VIRAL PROTEIN                           10-NOV-06   2NV3              
TITLE     SOLUTION STRUCTURE OF L8A MUTANT OF HIV-1 MYRISTOYLATED MATRIX PROTEIN
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: GAG POLYPROTEIN;                                           
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: MATRIX DOMAIN, RESIDUES 2-132;                             
COMPND   5 ENGINEERED: YES;                                                     
COMPND   6 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 
SOURCE   3 ORGANISM_TAXID: 11676;                                               
SOURCE   4 GENE: GAG;                                                           
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID                               
KEYWDS    L8A MUTANT OF HIV-1 MYRISTOYLATED MATRIX PROTEIN, VIRAL PROTEIN       
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    J.S.SAAD,E.LOELIGER,P.LUNCSFORD,M.LIRIANO,J.TAI,A.KIM,J.MILLER,       
AUTHOR   2 A.JOSHI,E.O.FREED,M.F.SUMMERS                                        
REVDAT   4   27-DEC-23 2NV3    1       REMARK                                   
REVDAT   3   20-OCT-21 2NV3    1       REMARK SEQADV LINK                       
REVDAT   2   24-FEB-09 2NV3    1       VERSN                                    
REVDAT   1   06-FEB-07 2NV3    0                                                
JRNL        AUTH   J.S.SAAD,E.LOELIGER,P.LUNCSFORD,M.LIRIANO,J.TAI,A.KIM,       
JRNL        AUTH 2 J.MILLER,A.JOSHI,E.O.FREED,M.F.SUMMERS                       
JRNL        TITL   POINT MUTATIONS IN THE HIV-1 MATRIX PROTEIN TURN OFF THE     
JRNL        TITL 2 MYRISTYL SWITCH.                                             
JRNL        REF    J.MOL.BIOL.                   V. 366   574 2007              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   17188710                                                     
JRNL        DOI    10.1016/J.JMB.2006.11.068                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CYANA                                                
REMARK   3   AUTHORS     : GUNTERT, MUMENTHALER AND WUTHRICH                    
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2NV3 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-NOV-06.                  
REMARK 100 THE DEPOSITION ID IS D_1000040337.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 308                                
REMARK 210  PH                             : 5.5                                
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 1 MM [U-100% 13C, U-100% 15N]      
REMARK 210                                   HIV-1 L8A-MYRMA, 50 MM SODIUM      
REMARK 210                                   PHOSPHATE, 100 MM NACL, 5 MM DTT,  
REMARK 210                                   90% H2O, 10% D2O; 1 MM [U-100%     
REMARK 210                                   15N] HIV-1 L8A-MYRMA, 50 MM        
REMARK 210                                   SODIUM PHOSPHATE, 100 MM NACL, 5   
REMARK 210                                   MM DTT, 90% H2O, 10% D2O; 1 MM     
REMARK 210                                   HIV-1 L8A-MYRMA, 50 MM SODIUM      
REMARK 210                                   PHOSPHATE, 100 MM NACL, 5 MM DTT,  
REMARK 210                                   90% H2O, 10% D2O                   
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D 1H-1H NOESY; 3D_15N             
REMARK 210                                   -SEPARATED_NOESY; 3D_13C-          
REMARK 210                                   SEPARATED_NOESY; 4D_13C/15N-       
REMARK 210                                   SEPARATED_NOESY; 4D_13C-           
REMARK 210                                   SEPARATED_NOESY; 2D 1H-15N HSQC;   
REMARK 210                                   3D HNCA; 3D HN(CO)CA               
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ; 800 MHZ                   
REMARK 210  SPECTROMETER MODEL             : DMX; DRX                           
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : DISTANCE GEOMETRY                  
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 50                                 
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : TARGET FUNCTION                    
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 SER A   6       38.43   -167.68                                   
REMARK 500  1 ALA A   8      -66.96   -179.58                                   
REMARK 500  1 SER A   9       60.68     68.59                                   
REMARK 500  1 PRO A  66        0.03    -69.75                                   
REMARK 500  1 ARG A  91       47.39     70.86                                   
REMARK 500  1 ALA A 115       35.65   -148.18                                   
REMARK 500  1 VAL A 128     -176.26    -68.28                                   
REMARK 500  1 GLN A 130       71.70   -157.60                                   
REMARK 500  2 ARG A   4       71.27     47.47                                   
REMARK 500  2 SER A   6       96.52     59.39                                   
REMARK 500  2 ALA A   8      -71.06    -85.02                                   
REMARK 500  2 SER A   9       61.59     65.16                                   
REMARK 500  2 PRO A  66        0.06    -69.79                                   
REMARK 500  2 THR A  70       39.16    -94.49                                   
REMARK 500  2 SER A  72     -165.97    -79.61                                   
REMARK 500  2 ARG A  91       -0.70     73.19                                   
REMARK 500  2 ASP A 121      -61.47   -174.08                                   
REMARK 500  3 SER A   6       30.50   -167.39                                   
REMARK 500  3 VAL A   7      -49.49   -132.32                                   
REMARK 500  3 ALA A   8      -70.89   -172.34                                   
REMARK 500  3 SER A   9       63.87     68.67                                   
REMARK 500  3 ILE A  34      -70.45    -69.07                                   
REMARK 500  3 GLU A 105      -71.41    -71.36                                   
REMARK 500  3 LYS A 114      -72.16    -95.15                                   
REMARK 500  3 ALA A 119       46.84   -151.72                                   
REMARK 500  3 ALA A 120      -42.64   -145.27                                   
REMARK 500  4 ARG A   4     -168.52     50.06                                   
REMARK 500  4 SER A   6       37.11   -172.40                                   
REMARK 500  4 VAL A   7      -51.85   -123.87                                   
REMARK 500  4 ALA A   8      -67.41   -179.58                                   
REMARK 500  4 GLU A  52       48.75   -107.72                                   
REMARK 500  4 THR A  53      107.42    179.40                                   
REMARK 500  4 THR A  70       35.39   -143.19                                   
REMARK 500  4 SER A  72     -174.15    -65.06                                   
REMARK 500  4 GLU A 105      -71.61    -78.30                                   
REMARK 500  4 GLN A 117      -47.29   -146.83                                   
REMARK 500  4 ALA A 120       51.45   -109.72                                   
REMARK 500  4 ASP A 121      -58.59   -150.51                                   
REMARK 500  4 SER A 126     -179.00   -177.50                                   
REMARK 500  4 GLN A 130       39.19   -173.84                                   
REMARK 500  5 SER A   6      157.58     63.86                                   
REMARK 500  5 VAL A   7      -73.12    -96.55                                   
REMARK 500  5 GLU A  52       47.77    -98.93                                   
REMARK 500  5 THR A  53      111.46    179.74                                   
REMARK 500  5 SER A  72     -176.54    -59.48                                   
REMARK 500  5 ALA A 120       41.01   -155.96                                   
REMARK 500  5 ASN A 124      129.17   -173.46                                   
REMARK 500  5 ASN A 131      174.53     61.21                                   
REMARK 500  6 ALA A   3     -170.44    -60.60                                   
REMARK 500  6 ARG A   4      -74.84    -52.53                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS     213 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1                   
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 2H3I   RELATED DB: PDB                                   
REMARK 900 WILD-TYPE PROTEIN                                                    
REMARK 900 RELATED ID: 2JMG   RELATED DB: PDB                                   
REMARK 900 V7R MUTANT OF HIV-1 MYRMA                                            
DBREF  2NV3 A    2   132  UNP    Q72497   Q72497_9HIV1     2    132             
SEQADV 2NV3 ALA A    8  UNP  Q72497    LEU     8 ENGINEERED MUTATION            
SEQRES   1 A  131  GLY ALA ARG ALA SER VAL ALA SER GLY GLY GLU LEU ASP          
SEQRES   2 A  131  LYS TRP GLU LYS ILE ARG LEU ARG PRO GLY GLY LYS LYS          
SEQRES   3 A  131  GLN TYR LYS LEU LYS HIS ILE VAL TRP ALA SER ARG GLU          
SEQRES   4 A  131  LEU GLU ARG PHE ALA VAL ASN PRO GLY LEU LEU GLU THR          
SEQRES   5 A  131  SER GLU GLY CYS ARG GLN ILE LEU GLY GLN LEU GLN PRO          
SEQRES   6 A  131  SER LEU GLN THR GLY SER GLU GLU LEU ARG SER LEU TYR          
SEQRES   7 A  131  ASN THR ILE ALA VAL LEU TYR CYS VAL HIS GLN ARG ILE          
SEQRES   8 A  131  ASP VAL LYS ASP THR LYS GLU ALA LEU ASP LYS ILE GLU          
SEQRES   9 A  131  GLU GLU GLN ASN LYS SER LYS LYS LYS ALA GLN GLN ALA          
SEQRES  10 A  131  ALA ALA ASP THR GLY ASN ASN SER GLN VAL SER GLN ASN          
SEQRES  11 A  131  TYR                                                          
HET    MYR  A   1      42                                                       
HETNAM     MYR MYRISTIC ACID                                                    
FORMUL   2  MYR    C14 H28 O2                                                   
HELIX    1   1 GLY A   10  GLU A   17  1                                   8    
HELIX    2   2 LYS A   30  PHE A   44  1                                  15    
HELIX    3   3 ASN A   47  GLU A   52  5                                   6    
HELIX    4   4 THR A   53  GLN A   65  1                                  13    
HELIX    5   5 PRO A   66  LEU A   68  5                                   3    
HELIX    6   6 SER A   72  GLN A   90  1                                  19    
HELIX    7   7 ASP A   96  LYS A  114  1                                  19    
HELIX    8   8 ALA A  115  THR A  122  1                                   8    
LINK         C1  MYR A   1                 N   GLY A   2     1555   1555  1.33  
SITE     1 AC1  7 GLY A   2  ARG A   4  TRP A  16  ILE A  34                    
SITE     2 AC1  7 LEU A  51  GLU A  52  LEU A  85                               
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000